Literature DB >> 10094879

Macrophages and microvessel density in tumors of the ovary.

M Orre1, P A Rogers.   

Abstract

Macrophages are members of the mononuclear phagocyte system and synthesize and release many angiogenesis stimulators and inhibitors. Previous studies have demonstrated heterogeneous macrophage populations in ovarian tumors. The aim of this study was to compare macrophage number between different types of ovarian tumors and between regions of high (HVD) and average (AVD) microvessel density (MVD). Macrophages were visualized using CD68 antibody. Previously determined regions of HVD and AVD were located on CD68 immunostained sections and image analysis software was used to count the number of positively stained cells per square millimeter. CD68-positive macrophage number did not differ between benign, mucinous, and serous ovarian tumors or between regions of HVD and AVD (ANOVA; P > 0.05). In both HVD and AVD regions of benign tumors, macrophage number positively correlated with MVD (Spearman rank correlation coefficient; P < 0.03). In contrast, a small but significant negative correlation between macrophage number and MVD was observed in HVD regions of serous tumors (Spearman rank correlation coefficient; P > 0.05). Macrophage infiltration does not appear to differ between ovarian tumor types; however, macrophages may have a positive influence on the vascularization of benign ovarian tumors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10094879     DOI: 10.1006/gyno.1998.5292

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma.

Authors:  C Subimerb; S Pinlaor; V Lulitanond; N Khuntikeo; S Okada; M S McGrath; S Wongkham
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer.

Authors:  C Lackner; Z Jukic; O Tsybrovskyy; G Jatzko; V Wette; G Hoefler; M Klimpfinger; H Denk; K Zatloukal
Journal:  Virchows Arch       Date:  2004-06-30       Impact factor: 4.064

3.  The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring.

Authors:  Matteo Vergati; Jeffrey Schlom; Kwong Y Tsang
Journal:  J Biomed Biotechnol       Date:  2011-01-20

4.  Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease.

Authors:  Xipeng Wang; Michael Deavers; Rebecca Patenia; Roland L Bassett; Peter Mueller; Qing Ma; Ena Wang; Ralph S Freedman
Journal:  J Transl Med       Date:  2006-07-06       Impact factor: 5.531

5.  Macrophages promote angiogenesis in human breast tumour spheroids in vivo.

Authors:  L Bingle; C E Lewis; K P Corke; M W R Reed; N J Brown
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

6.  Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models.

Authors:  Caterina Peraldo-Neia; Giuliana Cavalloni; Marco Soster; Loretta Gammaitoni; Serena Marchiò; Francesco Sassi; Livio Trusolino; Andrea Bertotti; Enzo Medico; Lorenzo Capussotti; Massimo Aglietta; Francesco Leone
Journal:  BMC Cancer       Date:  2014-12-05       Impact factor: 4.430

7.  Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours.

Authors:  G H Hall; L W Turnbull; I Richmond; L Helboe; S L Atkin
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

8.  Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment.

Authors:  Tamasin N Doig; David A Hume; Thanasis Theocharidis; John R Goodlad; Christopher D Gregory; Tom C Freeman
Journal:  BMC Genomics       Date:  2013-07-11       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.